Mycobacterium abscessus is a growing problem for people with CF across the globe. The Cystic Fibrosis Trust is investing in more long-term research to beat the bug!
Antimicrobial resistance (AMR) is a global concern but particularly so for people with cystic fibrosis (CF). Today we published the second ‘Research in focus’ report, on the work we are doing to tackle antimicrobial resistance. The report highlights the impact AMR has on the lives of people with CF and how our innovations into developing better, more effective treatments may help solve AMR for all those with drug-resistant infections.
Today we published the first of a new series of ‘Research in focus’ reports, on CF-related diabetes. The report explains the impact CF-related diabetes has on the lives of people with cystic fibrosis (CF), what we’ve learnt from our funding so far, and how a new Strategic Research Centre grant could pave the way for insulin-injection free treatments in the future.
A team of researchers from Imperial College London working on the Cystic Fibrosis Trust-funded Pseudomonas Strategic Research Centre (SRC), led by Professor Jane Davies, has developed a tool that 'lights up' when it detects the bug in the sputum of people with cystic fibrosis (CF).
The Cystic Fibrosis Trust has part-funded research that provides new understanding of ‘silent changes’ in the cystic fibrosis (CF) gene, which has been publish in PLoS Biology.
Welcome to Research Blast, a new feature that’s bringing you snippets of the ground-breaking research being funded by the Cystic Fibrosis Trust. In this first feature, we explain some of the research underway at the UK Cystic Fibrosis Innovation Hub based at Cambridge University. Find out how War and Peace, Sat Navs and the mission to put a man on Mars figure in the latest CF research!
